Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

uBiome

uBiome
2012 FOUNDED
PRIVATE STATUS
91-100 EMPLOYEES
Bankr. Admin/Reorg LATEST DEAL TYPE
Description

Provider of sequencing-based clinical microbiome tests designed to gather, analyze and translate data about the human microbiome. The company combines precision sequencing with machine learning and artificial intelligence to advance the science of the microbiome and make it useful, enabling doctors to get the accurate and required result to treat their patients and patients to take greater and better care of their health.

Website
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Primary Office
  • 360 Langton Street
  • San Francisco, CA 94103
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore uBiome’s full profile, request a free trial.

uBiome Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Admin/Reorg 04-Sep-2019 Completed Bankruptcy: Admin/Reorg
10. Later Stage VC (Series C) 21-Sep-2018 0000 00000 00000 Completed Generating Revenue
9. Early Stage VC (Series B) 29-Nov-2016 000.00 000.00 0000 Completed Generating Revenue
8. Accelerator/Incubator 24-Jun-2015 00.000 Completed Startup
7. Product Crowdfunding 25-Apr-2015 000.00 00.000 Completed Startup
6. Accelerator/Incubator 19-Aug-2014 00000 00.000 00.000 Completed Startup
5. Early Stage VC (Series A) 01-Jun-2014 00.00 00.00 000.00 Completed Startup
4. Seed Round 29-Oct-2013 Completed Startup
3. Product Crowdfunding 30-Sep-2013 $350K Completed Startup
2. Product Crowdfunding 19-Feb-2013 $361K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

uBiome Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 17,565,505 $0.000100 $0.07 $1.14 $1.14 1x $1.14 19.18%
Series A 18,111,922 $0.000100 $0.02 $0.34 $0.34 1x $0.34 19.78%
To view this company’s complete Cap Table, request access »

uBiome Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Finch Therapeutics Venture Capital-Backed Somerville, MA 00 00000 00000000000 00000
0000000000 Venture Capital-Backed Austin, TX 00 000.00 00000000000 000.00
00000 Venture Capital-Backed Bellevue, WA 000 000.00 00000000000 000.00
000000 Venture Capital-Backed San Jose, CA 0 00.000 00000 00.000
To view this company’s complete list of competitors, request access »

uBiome Executive Team (10)

Name Title Board
Seat
Contact
Info
Curtis Solsvig III Interim Chief Executive Officer
Robin Chiu Chief Financial Officer
Karthik Bhavaraju Chief Operating Officer
Pablo Valenzuela Ph.D Advisor

6 Former Executives

You’re viewing 4 of 10 executives. Get the full list »

uBiome Board Members (2)

Name Representing Role Since Contact
Info
Kimberly Scotti 8VC Board Member 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »